APO Research
Talk to an analyst

APO RESEARCH · REPORT

Calming and Sleeping

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Calming and Sleeping Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025197 pages

Choose your research edition.

Industry ResearchCalming and Sleeping Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Calming and Sleeping Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Calming and Sleeping Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Calming and Sleeping Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Calming and Sleeping Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Calming and Sleeping market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Calming and Sleeping is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Calming and Sleeping is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Calming and Sleeping is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Calming and Sleeping is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Calming and Sleeping include Teva Pharmaceutical, Johnson & Johnson, Eli Lilly, AstraZeneca, Sunovion Pharmaceuticals, Roscoe Medical, Durect, Collegium Pharmaceutical and Cara Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Calming and Sleeping market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Calming and Sleeping and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Calming and Sleeping sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Calming and Sleeping market size, projected growth trends, production technologies, key applications, and end-use industries.

Calming and Sleeping Segment by Company

Teva Pharmaceutical

Johnson & Johnson

Eli Lilly

AstraZeneca

Sunovion Pharmaceuticals

Roscoe Medical

Durect

Collegium Pharmaceutical

Cara Therapeutics

Acura Pharmaceuticals

Calming and Sleeping Segment by Type

Medications

Sleep Laboratories

Sleep Apnea Devices

Mattresses and Pillows

Prescriptions

Over-The-Counter (OTC)

Calming and Sleeping Segment by Application

Restless Leg Syndrome (RLS)

Narcolepsy

Sleepwalking

Bruxism

Insomnia

Sleep apnea

Calming and Sleeping Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calming and Sleeping market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Calming and Sleeping and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calming and Sleeping.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Calming and Sleeping market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Calming and Sleeping manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Calming and Sleeping in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Calming and Sleeping in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Calming and Sleeping Industry Trends Table 2. Calming and Sleeping Industry Drivers Table 3. Calming and Sleeping Industry Opportunities and Challenges Table 4. Calming and Sleeping Industry Restraints Table 5. Global Calming and Sleeping Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Calming and Sleeping Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Calming and Sleeping Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Calming and Sleeping Sales Market Share by Manufacturers Table 9. Global Calming and Sleeping Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Calming and Sleeping Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Calming and Sleeping Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Calming and Sleeping Manufacturers, Product Type & Application Table 13. Global Calming and Sleeping Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Calming and Sleeping by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Medications Table 17. Major Manufacturers of Sleep Laboratories Table 18. Major Manufacturers of Sleep Apnea Devices Table 19. Major Manufacturers of Mattresses and Pillows Table 20. Major Manufacturers of Prescriptions Table 21. Major Manufacturers of Over-The-Counter (OTC) Table 22. Global Calming and Sleeping Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Calming and Sleeping Sales by Type (2021-2026) & (K Units) Table 24. Global Calming and Sleeping Sales by Type (2027-2032) & (K Units) Table 25. Global Calming and Sleeping Sales Market Share by Type (2021-2026) Table 26. Global Calming and Sleeping Sales Market Share by Type (2027-2032) Table 27. Global Calming and Sleeping Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Calming and Sleeping Revenue by Type (2021-2026) & (K Units) Table 29. Global Calming and Sleeping Revenue by Type (2027-2032) & (K Units) Table 30. Global Calming and Sleeping Revenue Market Share by Type (2021-2026) Table 31. Global Calming and Sleeping Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Restless Leg Syndrome (RLS) Table 33. Major Manufacturers of Narcolepsy Table 34. Major Manufacturers of Sleepwalking Table 35. Major Manufacturers of Bruxism Table 36. Major Manufacturers of Insomnia Table 37. Major Manufacturers of Sleep apnea Table 38. Global Calming and Sleeping Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Calming and Sleeping Sales by Application (2021-2026) & (K Units) Table 40. Global Calming and Sleeping Sales by Application (2027-2032) & (K Units) Table 41. Global Calming and Sleeping Sales Market Share by Application (2021-2026) Table 42. Global Calming and Sleeping Sales Market Share by Application (2027-2032) Table 43. Global Calming and Sleeping Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 44. Global Calming and Sleeping Revenue by Application (2021-2026) & (K Units) Table 45. Global Calming and Sleeping Revenue by Application (2027-2032) & (K Units) Table 46. Global Calming and Sleeping Revenue Market Share by Application (2021-2026) Table 47. Global Calming and Sleeping Revenue Market Share by Application (2027-2032) Table 48. Global Calming and Sleeping Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 49. Global Calming and Sleeping Sales by Region (2021-2026) & (K Units) Table 50. Global Calming and Sleeping Sales Market Share by Region (2021-2026) Table 51. Global Calming and Sleeping Sales Forecasted by Region (2027-2032) & (K Units) Table 52. Global Calming and Sleeping Sales Forecasted Market Share by Region (2027-2032) Table 53. North America Calming and Sleeping Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. North America Calming and Sleeping Sales by Country (2021-2026) & (K Units) Table 55. North America Calming and Sleeping Sales by Country (2027-2032) & (K Units) Table 56. Europe Calming and Sleeping Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Europe Calming and Sleeping Sales by Country (2021-2026) & (K Units) Table 58. Europe Calming and Sleeping Sales by Country (2027-2032) & (K Units) Table 59. Asia Pacific Calming and Sleeping Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Asia Pacific Calming and Sleeping Sales by Country (2021-2026) & (K Units) Table 61. Asia Pacific Calming and Sleeping Sales by Country (2027-2032) & (K Units) Table 62. South America, Middle East and Africa Calming and Sleeping Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 63. South America, Middle East and Africa Calming and Sleeping Sales by Country (2021-2026) & (K Units) Table 64. South America, Middle East and Africa Calming and Sleeping Sales by Country (2027-2032) & (K Units) Table 65. Global Calming and Sleeping Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global Calming and Sleeping Revenue by Region (2021-2026) & (US$ Million) Table 67. Global Calming and Sleeping Revenue by Region (2027-2032) & (US$ Million) Table 68. Global Calming and Sleeping Revenue Market Share by Region (2021-2026) Table 69. Global Calming and Sleeping Revenue Market Share by Region (2027-2032) Table 70. Teva Pharmaceutical Company Information Table 71. Teva Pharmaceutical Business Overview Table 72. Teva Pharmaceutical Calming and Sleeping Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Teva Pharmaceutical Calming and Sleeping Product Portfolio Table 74. Teva Pharmaceutical Recent Development Table 75. Johnson & Johnson Company Information Table 76. Johnson & Johnson Business Overview Table 77. Johnson & Johnson Calming and Sleeping Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Johnson & Johnson Calming and Sleeping Product Portfolio Table 79. Johnson & Johnson Recent Development Table 80. Eli Lilly Company Information Table 81. Eli Lilly Business Overview Table 82. Eli Lilly Calming and Sleeping Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Eli Lilly Calming and Sleeping Product Portfolio Table 84. Eli Lilly Recent Development Table 85. AstraZeneca Company Information Table 86. AstraZeneca Business Overview Table 87. AstraZeneca Calming and Sleeping Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. AstraZeneca Calming and Sleeping Product Portfolio Table 89. AstraZeneca Recent Development Table 90. Sunovion Pharmaceuticals Company Information Table 91. Sunovion Pharmaceuticals Business Overview Table 92. Sunovion Pharmaceuticals Calming and Sleeping Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Sunovion Pharmaceuticals Calming and Sleeping Product Portfolio Table 94. Sunovion Pharmaceuticals Recent Development Table 95. Roscoe Medical Company Information Table 96. Roscoe Medical Business Overview Table 97. Roscoe Medical Calming and Sleeping Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Roscoe Medical Calming and Sleeping Product Portfolio Table 99. Roscoe Medical Recent Development Table 100. Durect Company Information Table 101. Durect Business Overview Table 102. Durect Calming and Sleeping Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Durect Calming and Sleeping Product Portfolio Table 104. Durect Recent Development Table 105. Collegium Pharmaceutical Company Information Table 106. Collegium Pharmaceutical Business Overview Table 107. Collegium Pharmaceutical Calming and Sleeping Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Collegium Pharmaceutical Calming and Sleeping Product Portfolio Table 109. Collegium Pharmaceutical Recent Development Table 110. Cara Therapeutics Company Information Table 111. Cara Therapeutics Business Overview Table 112. Cara Therapeutics Calming and Sleeping Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Cara Therapeutics Calming and Sleeping Product Portfolio Table 114. Cara Therapeutics Recent Development Table 115. Acura Pharmaceuticals Company Information Table 116. Acura Pharmaceuticals Business Overview Table 117. Acura Pharmaceuticals Calming and Sleeping Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Acura Pharmaceuticals Calming and Sleeping Product Portfolio Table 119. Acura Pharmaceuticals Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Calming and Sleeping Distributors List Table 123. Calming and Sleeping Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Calming and Sleeping Product Image Figure 2. Global Calming and Sleeping Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Calming and Sleeping Market Size (2021-2032) & (US$ Million) Figure 4. Global Calming and Sleeping Sales (2021-2032) & (K Units) Figure 5. Global Calming and Sleeping Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Calming and Sleeping Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Medications Image Figure 9. Sleep Laboratories Image Figure 10. Sleep Apnea Devices Image Figure 11. Mattresses and Pillows Image Figure 12. Prescriptions Image Figure 13. Over-The-Counter (OTC) Image Figure 14. Global Calming and Sleeping Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Calming and Sleeping Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Calming and Sleeping Sales Market Share by Type (2021-2032) Figure 17. Global Calming and Sleeping Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Calming and Sleeping Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Calming and Sleeping Revenue Market Share by Type (2021-2032) Figure 20. Restless Leg Syndrome (RLS) Image Figure 21. Narcolepsy Image Figure 22. Sleepwalking Image Figure 23. Bruxism Image Figure 24. Insomnia Image Figure 25. Sleep apnea Image Figure 26. Global Calming and Sleeping Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Calming and Sleeping Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global Calming and Sleeping Sales Market Share by Application (2021-2032) Figure 29. Global Calming and Sleeping Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Calming and Sleeping Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global Calming and Sleeping Revenue Market Share by Application (2021-2032) Figure 32. North America Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 33. North America Calming and Sleeping Sales Market Share by Country (2021-2032) Figure 34. U.S. Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Canada Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Mexico Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Europe Calming and Sleeping Sales Market Share by Country (2021-2032) Figure 39. Germany Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 40. France Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 41. U.K. Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Italy Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Netherlands Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Asia Pacific Calming and Sleeping Sales Market Share by Country (2021-2032) Figure 46. China Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Japan Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Korea Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Southeast Asia Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 50. India Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Australia Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South America, Middle East and Africa Calming and Sleeping Sales Market Share by Country (2021-2032) Figure 54. Brazil Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 55. South Africa Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Saudi Arabia Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Turkey Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Argentina Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 59. UAE Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Egypt Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Chile Calming and Sleeping Sales and Growth Rate (2021-2032) & (K Units) Figure 62. Global Calming and Sleeping Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global Calming and Sleeping Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America Calming and Sleeping Revenue (2021-2032) & (US$ Million) Figure 65. North America Calming and Sleeping Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe Calming and Sleeping Revenue (2021-2032) & (US$ Million) Figure 67. Europe Calming and Sleeping Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Calming and Sleeping Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific Calming and Sleeping Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa Calming and Sleeping Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa Calming and Sleeping Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. Calming and Sleeping Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Calming and Sleeping Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Medications
  • Sleep Laboratories
  • Sleep Apnea Devices
  • Mattresses and Pillows
  • Prescriptions
  • Over-The-Counter (OTC)
Applications
  • Restless Leg Syndrome (RLS)
  • Narcolepsy
  • Sleepwalking
  • Bruxism
  • Insomnia
  • Sleep apnea
Companies covered
  • Teva Pharmaceutical
  • Johnson & Johnson
  • Eli Lilly
  • AstraZeneca
  • Sunovion Pharmaceuticals
  • Roscoe Medical
  • Durect
  • Collegium Pharmaceutical
  • Cara Therapeutics
  • Acura Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Calming and Sleeping Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Calming and Sleeping Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Calming and Sleeping Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Calming and Sleeping Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Calming and Sleeping Market Dynamics
  1. 2.1 Calming and Sleeping Industry Trends
  2. 2.2 Calming and Sleeping Industry Drivers
  3. 2.3 Calming and Sleeping Industry Opportunities and Challenges
  4. 2.4 Calming and Sleeping Industry Restraints
3 Calming and Sleeping Market by Manufacturers
  1. 3.1 Global Calming and Sleeping Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Calming and Sleeping Sales by Manufacturers (2021-2026)
  3. 3.3 Global Calming and Sleeping Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Calming and Sleeping Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Calming and Sleeping Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Calming and Sleeping Manufacturers, Product Type & Application
  7. 3.7 Global Calming and Sleeping Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Calming and Sleeping Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Calming and Sleeping Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Calming and Sleeping Tier 1, Tier 2, and Tier 3
4 Calming and Sleeping Market by Type
  1. 4.1 Calming and Sleeping Type Introduction
  2. 4.1.1 Medications
  3. 4.1.2 Sleep Laboratories
  4. 4.1.3 Sleep Apnea Devices
  5. 4.1.4 Mattresses and Pillows
  6. 4.1.5 Prescriptions
  7. 4.1.6 Over-The-Counter (OTC)
  8. 4.2 Global Calming and Sleeping Sales by Type
  9. 4.2.1 Global Calming and Sleeping Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Calming and Sleeping Sales by Type (2021-2032)
  11. 4.2.3 Global Calming and Sleeping Sales Market Share by Type (2021-2032)
  12. 4.3 Global Calming and Sleeping Revenue by Type
  13. 4.3.1 Global Calming and Sleeping Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Calming and Sleeping Revenue by Type (2021-2032)
  15. 4.3.3 Global Calming and Sleeping Revenue Market Share by Type (2021-2032)
5 Calming and Sleeping Market by Application
  1. 5.1 Calming and Sleeping Application Introduction
  2. 5.1.1 Restless Leg Syndrome (RLS)
  3. 5.1.2 Narcolepsy
  4. 5.1.3 Sleepwalking
  5. 5.1.4 Bruxism
  6. 5.1.5 Insomnia
  7. 5.1.6 Sleep apnea
  8. 5.2 Global Calming and Sleeping Sales by Application
  9. 5.2.1 Global Calming and Sleeping Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Calming and Sleeping Sales by Application (2021-2032)
  11. 5.2.3 Global Calming and Sleeping Sales Market Share by Application (2021-2032)
  12. 5.3 Global Calming and Sleeping Revenue by Application
  13. 5.3.1 Global Calming and Sleeping Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Calming and Sleeping Revenue by Application (2021-2032)
  15. 5.3.3 Global Calming and Sleeping Revenue Market Share by Application (2021-2032)
6 Global Calming and Sleeping Sales by Region
  1. 6.1 Global Calming and Sleeping Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Calming and Sleeping Sales by Region (2021-2032)
  3. 6.2.1 Global Calming and Sleeping Sales by Region (2021-2026)
  4. 6.2.2 Global Calming and Sleeping Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Calming and Sleeping Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Calming and Sleeping Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Calming and Sleeping Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Calming and Sleeping Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Calming and Sleeping Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Calming and Sleeping Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Calming and Sleeping Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Calming and Sleeping Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Calming and Sleeping Revenue by Region
  1. 7.1 Global Calming and Sleeping Revenue by Region
  2. 7.1.1 Global Calming and Sleeping Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Calming and Sleeping Revenue by Region (2021-2026)
  4. 7.1.3 Global Calming and Sleeping Revenue by Region (2027-2032)
  5. 7.1.4 Global Calming and Sleeping Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Calming and Sleeping Revenue (2021-2032)
  8. 7.2.2 North America Calming and Sleeping Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Calming and Sleeping Revenue (2021-2032)
  11. 7.3.2 Europe Calming and Sleeping Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Calming and Sleeping Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Calming and Sleeping Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Calming and Sleeping Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Calming and Sleeping Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Calming and Sleeping Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Calming and Sleeping Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Calming and Sleeping Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Calming and Sleeping Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Eli Lilly
  14. 8.3.1 Eli Lilly Company Information
  15. 8.3.2 Eli Lilly Business Overview
  16. 8.3.3 Eli Lilly Calming and Sleeping Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly Calming and Sleeping Product Portfolio
  18. 8.3.5 Eli Lilly Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Calming and Sleeping Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Calming and Sleeping Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Sunovion Pharmaceuticals
  26. 8.5.1 Sunovion Pharmaceuticals Company Information
  27. 8.5.2 Sunovion Pharmaceuticals Business Overview
  28. 8.5.3 Sunovion Pharmaceuticals Calming and Sleeping Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sunovion Pharmaceuticals Calming and Sleeping Product Portfolio
  30. 8.5.5 Sunovion Pharmaceuticals Recent Developments
  31. 8.6 Roscoe Medical
  32. 8.6.1 Roscoe Medical Company Information
  33. 8.6.2 Roscoe Medical Business Overview
  34. 8.6.3 Roscoe Medical Calming and Sleeping Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Roscoe Medical Calming and Sleeping Product Portfolio
  36. 8.6.5 Roscoe Medical Recent Developments
  37. 8.7 Durect
  38. 8.7.1 Durect Company Information
  39. 8.7.2 Durect Business Overview
  40. 8.7.3 Durect Calming and Sleeping Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Durect Calming and Sleeping Product Portfolio
  42. 8.7.5 Durect Recent Developments
  43. 8.8 Collegium Pharmaceutical
  44. 8.8.1 Collegium Pharmaceutical Company Information
  45. 8.8.2 Collegium Pharmaceutical Business Overview
  46. 8.8.3 Collegium Pharmaceutical Calming and Sleeping Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Collegium Pharmaceutical Calming and Sleeping Product Portfolio
  48. 8.8.5 Collegium Pharmaceutical Recent Developments
  49. 8.9 Cara Therapeutics
  50. 8.9.1 Cara Therapeutics Company Information
  51. 8.9.2 Cara Therapeutics Business Overview
  52. 8.9.3 Cara Therapeutics Calming and Sleeping Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cara Therapeutics Calming and Sleeping Product Portfolio
  54. 8.9.5 Cara Therapeutics Recent Developments
  55. 8.10 Acura Pharmaceuticals
  56. 8.10.1 Acura Pharmaceuticals Company Information
  57. 8.10.2 Acura Pharmaceuticals Business Overview
  58. 8.10.3 Acura Pharmaceuticals Calming and Sleeping Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Acura Pharmaceuticals Calming and Sleeping Product Portfolio
  60. 8.10.5 Acura Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Calming and Sleeping Value Chain Analysis
  2. 9.1.1 Calming and Sleeping Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Calming and Sleeping Production Mode & Process
  6. 9.2 Calming and Sleeping Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Calming and Sleeping Distributors
  9. 9.2.3 Calming and Sleeping Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst